Although rare, sarcoidosis-like granulomatous reactions ... Sarcoidosis is a chronic, multisystem disease of unknown etiology that is histologically characterized by non-necrotizing epithelioid-cell ...

But they are still investigating its source. US aid cuts are hurting Africa’s ability to respond to disease outbreaks, health chief says Measles cases reach nearly 300 total in Texas and New Mexico.

Dr. Jennifer Flemming said there is an “urgent need” to identify risk groups and intervene with treatment and disease management Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has ...

It added: "Still, it means it has the potential to fight the inflammation that plays a role in many health conditions and diseases. That’s why anything that can help fight chronic inflammation ...

Welcome to the homepage for the Economic Burden of Illness in Canada (EBIC) report. EBIC provides academics, researchers, decision-makers, and policy-makers with objective and comparable information ...

iStock Lillia’s clinically proven, AI-powered platform enables healthcare providers, insurers, corporations and public sector entities to manage chronic diseases effectively. DOHA: Lillia, an AI ...

However, a slit lamp examination combined with negative bacterial and fungal staining and culturing should lead to a diagnosis of foreign body granuloma. Written informed consent was obtained from ...

The study found that one in six people in the region die before the age of 70 from chronic diseases such as cardiovascular disease, cancer, diabetes or chronic respiratory diseases. “THE REGION AS A ...

However, prolonged inflammation can lead to many serious health issues like arthritis, heart disease, and cancer. Understanding how chronic inflammation impacts our well-being and how blood tests can ...

POSEY COUNTY, Ind. (WTHI) - The Indiana Department of Natural Resources has confirmed a second case of chronic wasting disease from a deer in the state. Chronic wasting disease (CWD) is a neurological ...

today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease (“cLDD”).